The Oligodendroglial Lineage Marker OLIG2 Is Universally Expressed in Diffuse Gliomas
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Astrocytomas, oligodendrogliomas, and oligoastrocytomas, collectively referred to as diffuse gliomas, are the most common primary brain tumors. These tumors are classified by histologic similarity to differentiated astrocytes and oligodendrocytes, but this approach has major limitations in guiding modern treatment and research. Lineage markers represent a potentially useful adjunct to morphologic classification. The murine bHLH transcription factors Olig1 and Olig2 are expressed in neural progenitors and oligodendroglia and are essential for oligodendrocyte development. High OLIG expression alone has been proposed to distinguish oligodendrogliomas from astrocytomas, so we critically evaluated OLIG2 as a marker by immunohistochemical and oligonucleotide microarray analysis. OLIG2 protein is faithfully restricted to normal oligodendroglia and their progenitors in human brain. Immunohistochemical analysis of 180 primary, metastatic, and non-neural human tumors shows OLIG2 is highly expressed in all diffuse gliomas. Immunohistochemistry and microarray analyses demonstrate higher OLIG2 in anaplastic oligodendrogliomas versus glioblastomas, which are heterogeneous with respect to OLIG2 levels. OLIG2 protein expression is present but inconsistent and generally lower in most other brain tumors and is absent in non-neuroectodermal tumors. Overall, OLIG2 is a useful marker of diffuse gliomas as a class. However, expression heterogeneity of OLIG2 in astrocytomas precludes immunohistochemical classification of individual gliomas by OLIG2 alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
Numerical recipes in C: the art of scientific computing
(1993) · Choice Reviews Online · doi:10.5860/choice.30-5638 · Cited by 17,933
Numerical recipes in Pascal: the art of scientific computing
(1990) · Choice Reviews Online · doi:10.5860/choice.27-5158 · Cited by 11,811
Gage, F. H. (2000) · Science · doi:10.1126/science.287.5457.1433 · Cited by 4,786
Malignant glioma: genetics and biology of a grave matter
Maher, E. A., Furnari, F. B., Bachoo, R. M., Rowitch, D. H., Louis, D. N., Cavenee, W. K., & DePinho, R. A. (2001) · Genes & Development · doi:10.1101/gad.891601 · Cited by 1,229
Self-citationLu, Q. R., Sun, T., Zhu, Z., Ma, N., Garcia, M., Stiles, C. D., & Rowitch, D. H. (2002) · Cell · doi:10.1016/s0092-8674(02)00678-5 · Cited by 1,073
Self-citationNutt, C. L., Mani, D. R., Betensky, R. A., Tamayo, P., Cairncross, J. G., Ladd, C., Pohl, U., Hartmann, C. J., McLaughlin, M. E., Batchelor, T. T., et al. (2003) · PubMed · Cited by 1,066
Self-citationThe bHLH Transcription Factors OLIG2 and OLIG1 Couple Neuronal and Glial Subtype Specification
Zhou, Q., & Anderson, D. J. (2002) · Cell · doi:10.1016/s0092-8674(02)00677-3 · Cited by 1,059
A long, remarkable journey: Tangential migration in the telencephalon
Marín, O., & Rubenstein, J. L. R. (2001) · Nature Reviews Neuroscience · doi:10.1038/35097509 · Cited by 1,059
Ignatova, T. N., Kukekov, V. G., Laywell, E. D., Suslov, O. N., Vrionis, F. D., & Steindler, D. A. (2002) · Glia · doi:10.1002/glia.10094 · Cited by 992
Lu, Q. R., Yuk, D.-I., Alberta, J. A., Zhu, Z., Pawlitzky, I., Chan, J., McMahon, A. P., Stiles, C. D., & Rowitch, D. H. (2000) · Neuron · doi:10.1016/s0896-6273(00)80897-1 · Cited by 852
Self-citationZhou, Q., Wang, S., & Anderson, D. J. (2000) · Neuron · doi:10.1016/s0896-6273(00)80898-3 · Cited by 789
Epidermal growth factor receptor and Ink4a/Arf
Bachoo, R. M., Maher, E. A., Ligon, K. L., Sharpless, N. E., Chan, S. S., You, M. J., Tang, Y., DeFrances, J., Stover, E., Weissleder, R., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00046-6 · Cited by 652
Self-citationNovitch, B. G., Chen, A. I., & Jessell, T. M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00407-x · Cited by 615 · cited 1×
“Although OLIG2 is expressed in undifferentiated progenitor cells that can give rise to neurons, its expression is reportedly not maintained in the neuronal progeny of these cells (29).”
BackgroundBasic Helix-Loop-Helix Factors in Cortical Development
Ross, S. E., Greenberg, M. E., & Stiles, C. D. (2003) · Neuron · doi:10.1016/s0896-6273(03)00365-9 · Cited by 599
Self-citation(1926) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1926.02680040056039 · Cited by 583
Mizuguchi, R., Sugimori, M., Takebayashi, H., Kosako, H., Nagao, M., Yoshida, S., Nabeshima, Y.-I., Shimamura, K., & Nakafuku, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00413-5 · Cited by 436
Identification of neural stem cells in the adult vertebrate brain
Alvarez-Buylla, A., Seri, B., & Doetsch, F. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00770-5 · Cited by 413
Takebayashi, H., Yoshida, S., Sugimori, M., Kosako, H., Kominami, R., Nakafuku, M., & Nabeshima, Y.-I. (2000) · Mechanisms of Development · doi:10.1016/s0925-4773(00)00466-4 · Cited by 386
Expression of the class VI intermediate filament nestin in human central nervous system tumors.
Dahlstrand, J., Collins, V. P., & Lendahl, U. (1992) · PubMed · Cited by 367
Successful chemotherapy for recurrent malignant oligodendroglioma
Cairncross, J. G., & Macdonald, D. R. (1988) · Annals of Neurology · doi:10.1002/ana.410230408 · Cited by 344
olig2 Is Required for Zebrafish Primary Motor Neuron and Oligodendrocyte Development
Park, H.-C., Mehta, A., Richardson, J. S., & Appel, B. (2002) · Developmental Biology · doi:10.1006/dbio.2002.0738 · Cited by 306
Louis, D. N., Holland, E. C., & Cairncross, J. G. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61750-6 · Cited by 298
Self-citationOligodendroglioma: Toward Molecular Definitions in Diagnostic Neuro-Oncology
Reifenberger, G., & Louis, D. N. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.2.111 · Cited by 296
Self-citationShoshan, Y., Nishiyama, A., Chang, A., Mörk, S., Barnett, G. H., Cowell, J. K., Trapp, B. D., & Staugaitis, S. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10361 · Cited by 190
Progenitor cells and glioma formation
Holland, E. C. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200112000-00002 · Cited by 183
An ‘oligarchy’ rules neural development
Rowitch, D. H., Lu, Q. R., Kessaris, N., & Richardson, W. D. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02201-4 · Cited by 181
Self-citationOligodendrocyte lineage genes ( OLIG ) as molecular markers for human glial brain tumors
Lu, Q. R., Park, J. K., Noll, E., Chan, J. A., Alberta, J., Yuk, D., Alzamora, M. G., Louis, D. N., Stiles, C. D., Rowitch, D. H., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181340798 · Cited by 176
Self-citationMutant Stem Cells May Seed Cancer
Marx, J. (2003) · Science · doi:10.1126/science.301.5638.1308 · Cited by 174
OLIG2 as a specific marker of oligodendroglial tumour cells
Marie, Y., Sanson, M., Mokhtari, K., Leuraud, P., Kujas, M., Delattre, J., Poirier, J. C., Zalc, B., & Hoang‐Xuan, K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05499-x · Cited by 144
Wang, J., Jani-Sait, S., Escalon, E., Carroll, A. J., de Jong, P. J., Kirsch, I. R., & Aplan, P. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3497 · Cited by 93
Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells
Bouvier, C., Bartoli, C., Aguirre‐Cruz, L., Virard, I., Colin, C., Fernandez, C., Gouvernet, J., & Figarella‐Branger, D. (2003) · Journal of neurosurgery · doi:10.3171/jns.2003.99.2.0344 · Cited by 91
Herpers, M. J. H. M., Ramaekers, F. C. S., Aldeweireldt, J., Moesker, O., & Slooff, J. (1986) · Acta Neuropathologica · doi:10.1007/bf00686093 · Cited by 86
Ohnishi, A., Sawa, H., Tsuda, M., Sawamura, Y., Itoh, T., Iwasaki, Y., & Nagashima, K. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.10.1052 · Cited by 84
Recent developments in the molecular characterization and treatment of oligodendroglial tumors
van den Bent, M. J., Chinot, O. L., & Cairncross, J. G. (2003) · Neuro-Oncology · doi:10.1093/neuonc/5.2.128 · Cited by 79
Medulloblastoma: A problem of developmental biology
Rubin, J. B., & Rowitch, D. H. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00090-9 · Cited by 59
Self-citationConstitutive Expression of Growth-related Oncogene and Its Receptor in Oligodendrogliomas
Robinson, S., Cohen, M. L., Prayson, R. A., Ransohoff, R. M., Tabrizi, N., & Miller, R. H. (2001) · Neurosurgery · doi:10.1097/0006123-200104000-00035 · Cited by 52
Noble, M., Gutowski, N. J., Bevan, K., Engel, U., Linskey, M. E., Urenjak, J., Bhakoo, K. K., & Williams, S. (1995) · Glia · doi:10.1002/glia.440150304 · Cited by 51
Astrocyte Differentiation States and Glioma Formation
Dai, C., & Holland, E. C. (2003) · The Cancer Journal · doi:10.1097/00130404-200303000-00002 · Cited by 48
CD44H is Expressed by cells of the Oligodendrocyte Lineage and by Oligodendrogliomas in Humans
Bouvier, C., Liprandi, A., Monti, G., Pellissier, J. F., & Figarella-Branger, D. F. (2002) · Journal of Neuro-Oncology · doi:10.1023/a:1020630732625 · Cited by 28
(2003) · PubMed
Cited by
Phillips, H. S., Kharbanda, S., Chen, R., Forrest, W. F., Soriano, R. H., Wu, T. D., Misra, A., Nigro, J. M., Colman, H., Soroceanu, L., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.02.019 · Cited by 3,143
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A., Stommel, J. M., Stegh, A., Hahn, W. C., Ligon, K. L., Louis, D. N., Brennan, C., et al. (2007) · Genes & Development · doi:10.1101/gad.1596707 · Cited by 2,316
“OLIG2, a more recently discovered stem/progenitor and oligodendroglial marker, is CNS specific and is universally and abundantly expressed in all diffuse gliomas, but is rarely expressed at such high levels in other types of gliomas and CNS malignancies (Ligon et al. 2004; Rous-seau et al. 2006).”
BackgroundSelf-citationSturm, D., Witt, H., Hovestadt, V., Khuong-Quang, D.-A., Jones, D. T. W., Konermann, C., Pfaff, E., Tönjes, M., Sill, M., Bender, S., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.024 · Cited by 1,828
Origin of oligodendrocytes in the subventricular zone of the adult brain
Menn, B., Garcia-Verdugo, J. M., Yaschine, C., Gonzalez-Perez, O., Rowitch, D., & Alvarez-Buylla, A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1299-06.2006 · Cited by 972
“…chicken monoclonal anti-GFP (1:1000; Aves Lab,Tigard, OR), rabbit polyclonal anti-oligodendrocyte lineage transcription factor 2 (Olig2) (1:5000) (Ligon et al., 2004), antiplatelet-derived growth factor receptor ␣ (PDGFR␣) (1:50; Santa Cruz Biotechnology, Santa Cruz, CA), for identification of…”
BackgroundMethodSelf-citationCoactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies
Stommel, J. M., Kimmelman, A. C., Ying, H., Nabioullin, R., Ponugoti, A. H., Wiedemeyer, R., Stegh, A. H., Bradner, J. E., Ligon, K. L., Brennan, C., et al. (2007) · Science · doi:10.1126/science.1142946 · Cited by 938
Self-citation
Metadata
- Authors
- Ligon, K. L., Alberta, J. A., Kho, A. T., Weiss, J., Kwaan, M. R., Nutt, C. L., Louis, D. N., Stiles, C. D., & Rowitch, D. H.
- Venue
- Journal of Neuropathology & Experimental Neurology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-05
- Volume
- 63
- Issue
- 5
- Pages
- 499-509
- ISSN
- 0022-3069 (ISSN-L)
- 1554-6578
- OpenAlex
- W155107415
- Cited by
- 438
- References
- 41
- FWCI
- 8.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.